| John T Schwent, DO | |
|
12303 Depaul Drive, Depaul Health Center, Bridgeton, MO 63044 | |
| (314) 344-6000 | |
| (630) 734-1560 |
| Full Name | John T Schwent |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 12303 Depaul Drive, Bridgeton, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790743029 | NPI | - | NPPES |
| 240691949 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | R6301 (Missouri) | Primary |
| Entity Name | Texas County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790740363 PECOS PAC ID: 9436041696 Enrollment ID: O20040401000307 |
News Archive
Columbia University Medical Center researchers have for the first time directly converted human skin cells into functional forebrain neurons, without the need for stem cells of any kind.
Scientists from the University of Sheffield have developed a novel antibody-based therapy which targets the progression of life threating kidney fibrosis.
Medidata Solutions has further expanded its Partner Program by naming EXTEDO, provider of regulatory information management software and service solutions, a Medidata Technology Partner. EXTEDO created an integration that utilizes Medidata Rave Safety Gateway to transfer critical safety data from Medidata Rave, a leading system for electronic data capture, clinical data management and reporting, into its PcVmanager drug safety management solution.
With the globalization of biomedical research and growing concerns about possible pandemics of diseases such as HIV, SARS, and Ebola, international data-sharing practices are of growing interest to the biomedical science community. But what are the advantages and disadvantages of sharing data in low and middle-income settings? What challenges stand in the way for researchers in countries such as India, Kenya, and Vietnam? A new special issue of SAGE's Journal of Empirical Research on Human Research Ethics presents guidelines, protocols, models, and new resources to improve data sharing across the globe.
Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of carcinoid syndrome, according to researchers at The University of Texas MD Anderson Cancer Center.
› Verified 4 days ago
| Entity Name | Mercy Hospital Lebanon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447284898 PECOS PAC ID: 7214829019 Enrollment ID: O20041021000208 |
News Archive
Columbia University Medical Center researchers have for the first time directly converted human skin cells into functional forebrain neurons, without the need for stem cells of any kind.
Scientists from the University of Sheffield have developed a novel antibody-based therapy which targets the progression of life threating kidney fibrosis.
Medidata Solutions has further expanded its Partner Program by naming EXTEDO, provider of regulatory information management software and service solutions, a Medidata Technology Partner. EXTEDO created an integration that utilizes Medidata Rave Safety Gateway to transfer critical safety data from Medidata Rave, a leading system for electronic data capture, clinical data management and reporting, into its PcVmanager drug safety management solution.
With the globalization of biomedical research and growing concerns about possible pandemics of diseases such as HIV, SARS, and Ebola, international data-sharing practices are of growing interest to the biomedical science community. But what are the advantages and disadvantages of sharing data in low and middle-income settings? What challenges stand in the way for researchers in countries such as India, Kenya, and Vietnam? A new special issue of SAGE's Journal of Empirical Research on Human Research Ethics presents guidelines, protocols, models, and new resources to improve data sharing across the globe.
Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of carcinoid syndrome, according to researchers at The University of Texas MD Anderson Cancer Center.
› Verified 4 days ago
| Entity Name | Southeastern Emergency Physicians Of Memphis Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437105277 PECOS PAC ID: 5395643209 Enrollment ID: O20060711000434 |
News Archive
Columbia University Medical Center researchers have for the first time directly converted human skin cells into functional forebrain neurons, without the need for stem cells of any kind.
Scientists from the University of Sheffield have developed a novel antibody-based therapy which targets the progression of life threating kidney fibrosis.
Medidata Solutions has further expanded its Partner Program by naming EXTEDO, provider of regulatory information management software and service solutions, a Medidata Technology Partner. EXTEDO created an integration that utilizes Medidata Rave Safety Gateway to transfer critical safety data from Medidata Rave, a leading system for electronic data capture, clinical data management and reporting, into its PcVmanager drug safety management solution.
With the globalization of biomedical research and growing concerns about possible pandemics of diseases such as HIV, SARS, and Ebola, international data-sharing practices are of growing interest to the biomedical science community. But what are the advantages and disadvantages of sharing data in low and middle-income settings? What challenges stand in the way for researchers in countries such as India, Kenya, and Vietnam? A new special issue of SAGE's Journal of Empirical Research on Human Research Ethics presents guidelines, protocols, models, and new resources to improve data sharing across the globe.
Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of carcinoid syndrome, according to researchers at The University of Texas MD Anderson Cancer Center.
› Verified 4 days ago
| Entity Name | Mercy St Francis Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1023053477 PECOS PAC ID: 7810806643 Enrollment ID: O20061104000139 |
News Archive
Columbia University Medical Center researchers have for the first time directly converted human skin cells into functional forebrain neurons, without the need for stem cells of any kind.
Scientists from the University of Sheffield have developed a novel antibody-based therapy which targets the progression of life threating kidney fibrosis.
Medidata Solutions has further expanded its Partner Program by naming EXTEDO, provider of regulatory information management software and service solutions, a Medidata Technology Partner. EXTEDO created an integration that utilizes Medidata Rave Safety Gateway to transfer critical safety data from Medidata Rave, a leading system for electronic data capture, clinical data management and reporting, into its PcVmanager drug safety management solution.
With the globalization of biomedical research and growing concerns about possible pandemics of diseases such as HIV, SARS, and Ebola, international data-sharing practices are of growing interest to the biomedical science community. But what are the advantages and disadvantages of sharing data in low and middle-income settings? What challenges stand in the way for researchers in countries such as India, Kenya, and Vietnam? A new special issue of SAGE's Journal of Empirical Research on Human Research Ethics presents guidelines, protocols, models, and new resources to improve data sharing across the globe.
Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of carcinoid syndrome, according to researchers at The University of Texas MD Anderson Cancer Center.
› Verified 4 days ago
| Entity Name | Fulton Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1417367665 PECOS PAC ID: 7810211398 Enrollment ID: O20150123001617 |
News Archive
Columbia University Medical Center researchers have for the first time directly converted human skin cells into functional forebrain neurons, without the need for stem cells of any kind.
Scientists from the University of Sheffield have developed a novel antibody-based therapy which targets the progression of life threating kidney fibrosis.
Medidata Solutions has further expanded its Partner Program by naming EXTEDO, provider of regulatory information management software and service solutions, a Medidata Technology Partner. EXTEDO created an integration that utilizes Medidata Rave Safety Gateway to transfer critical safety data from Medidata Rave, a leading system for electronic data capture, clinical data management and reporting, into its PcVmanager drug safety management solution.
With the globalization of biomedical research and growing concerns about possible pandemics of diseases such as HIV, SARS, and Ebola, international data-sharing practices are of growing interest to the biomedical science community. But what are the advantages and disadvantages of sharing data in low and middle-income settings? What challenges stand in the way for researchers in countries such as India, Kenya, and Vietnam? A new special issue of SAGE's Journal of Empirical Research on Human Research Ethics presents guidelines, protocols, models, and new resources to improve data sharing across the globe.
Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of carcinoid syndrome, according to researchers at The University of Texas MD Anderson Cancer Center.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John T Schwent, DO Po Box 4853, Dept 4036 Midwest Emergency Associates - Depaul Llc, Oak Brook, IL 60522 Ph: (636) 734-0200 | John T Schwent, DO 12303 Depaul Drive, Depaul Health Center, Bridgeton, MO 63044 Ph: (314) 344-6000 |
News Archive
Columbia University Medical Center researchers have for the first time directly converted human skin cells into functional forebrain neurons, without the need for stem cells of any kind.
Scientists from the University of Sheffield have developed a novel antibody-based therapy which targets the progression of life threating kidney fibrosis.
Medidata Solutions has further expanded its Partner Program by naming EXTEDO, provider of regulatory information management software and service solutions, a Medidata Technology Partner. EXTEDO created an integration that utilizes Medidata Rave Safety Gateway to transfer critical safety data from Medidata Rave, a leading system for electronic data capture, clinical data management and reporting, into its PcVmanager drug safety management solution.
With the globalization of biomedical research and growing concerns about possible pandemics of diseases such as HIV, SARS, and Ebola, international data-sharing practices are of growing interest to the biomedical science community. But what are the advantages and disadvantages of sharing data in low and middle-income settings? What challenges stand in the way for researchers in countries such as India, Kenya, and Vietnam? A new special issue of SAGE's Journal of Empirical Research on Human Research Ethics presents guidelines, protocols, models, and new resources to improve data sharing across the globe.
Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of carcinoid syndrome, according to researchers at The University of Texas MD Anderson Cancer Center.
› Verified 4 days ago
Dr. Harlan Dru Hodges, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 12303 Depaul Dr, Depaul Health Center, Bridgeton, MO 63044 Phone: 314-344-6000 Fax: 630-734-1560 | |
Norman J Ehlinger Jr., DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3436a Mckelvey Rd, Bridgeton, MO 63044 Phone: 314-739-5518 Fax: 314-739-1223 | |
Laura Marie Viero-dothage, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 12303 Depaul Dr, Depaul Health Center, Bridgeton, MO 63044 Phone: 314-344-6000 Fax: 630-734-1560 | |
Dr. Anil Kumar Srivastava, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 12266 De Paul Dr Ste 305, Bridgeton, MO 63044 Phone: 314-770-0991 | |
Timothy F Reed, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 12303 Depaul Drive, Bridgeton, MO 63044 Phone: 314-344-6000 | |
Andrew J Wahle, PA Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 12303 Depaul Dr, Depaul Health Center, Bridgeton, MO 63044 Phone: 314-344-6000 Fax: 630-734-1560 | |
Gilbert N Jones, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 12303 Depaul Drive, Bridgeton, MO 63044 Phone: 314-344-6000 |